000 | 01835 a2200529 4500 | ||
---|---|---|---|
005 | 20250515223852.0 | ||
264 | 0 | _c20100916 | |
008 | 201009s 0 0 eng d | ||
022 | _a1538-8514 | ||
024 | 7 |
_a10.1158/1535-7163.MCT-09-1173 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMunshi, Neru | |
245 | 0 | 0 |
_aARQ 197, a novel and selective inhibitor of the human c-Met receptor tyrosine kinase with antitumor activity. _h[electronic resource] |
260 |
_bMolecular cancer therapeutics _cJun 2010 |
||
300 |
_a1544-53 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 |
_aCaspases _xmetabolism |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunosuppression Therapy |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Nude |
650 | 0 | 4 |
_aNeoplasms _xenzymology |
650 | 0 | 4 |
_aPhosphorylation _xdrug effects |
650 | 0 | 4 |
_aProtein Kinase Inhibitors _xchemistry |
650 | 0 | 4 | _aProto-Oncogene Mas |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-met _xantagonists & inhibitors |
650 | 0 | 4 |
_aPyrroles _xchemistry |
650 | 0 | 4 |
_aPyrrolidinones _xchemistry |
650 | 0 | 4 |
_aQuinolines _xchemistry |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
650 | 0 | 4 | _aXenograft Model Antitumor Assays |
700 | 1 | _aJeay, Sébastien | |
700 | 1 | _aLi, Youzhi | |
700 | 1 | _aChen, Chang-Rung | |
700 | 1 | _aFrance, Dennis S | |
700 | 1 | _aAshwell, Mark A | |
700 | 1 | _aHill, Jason | |
700 | 1 | _aMoussa, Magdi M | |
700 | 1 | _aLeggett, David S | |
700 | 1 | _aLi, Chiang J | |
773 | 0 |
_tMolecular cancer therapeutics _gvol. 9 _gno. 6 _gp. 1544-53 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1158/1535-7163.MCT-09-1173 _zAvailable from publisher's website |
999 |
_c19837816 _d19837816 |